Medicare Enrolled
Dr. Catherine Harris, M.D.
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician · Morehead City, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harris from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harris?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harris
Dr. Catherine Harris is an urogynecology and reconstructive pelvic surgery physician in Morehead City, NC, with 16 years of NPI registration. Based on federal Medicare data, Dr. Harris performed 8,367 Medicare services across 1,620 unique beneficiaries.
Between the years covered by Open Payments, Dr. Harris received a total of $9,955 from 67 pharmaceutical and/or device companies across 369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urogynecology and reconstructive pelvic surgery (urology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harris is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ 8,367 Medicare services
$9,955 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,367
Medicare services
Bottom 25% in NC for urogynecology and reconstructive pelvic surgery (urology) physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,620
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~523 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
5,550 | $5 | $11 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
455 | $34 | $105 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
369 | $2 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
348 | $69 | $231 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $102 | $335 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
198 | $98 | $404 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
175 | $34 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
153 | $130 | $506 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
148 | $9 | $32 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
94 | $198 | $602 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
65 | $51 | $191 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
49 | $64 | $279 |
| Catheter specimen collection A procedure to collect a specimen using a catheter. This service is available in all places of service. |
45 | $8 | $10 |
| Fitting and insertion of vaginal support device A procedure to measure, fit, and insert a device designed to support vaginal structures. |
43 | $58 | $214 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
42 | $84 | $332 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
36 | $69 | $210 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
35 | $34 | $105 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
35 | $34 | $105 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
35 | $34 | $105 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
35 | $34 | $105 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
35 | $34 | $105 |
| Non-rubber pessary A non-rubber device inserted into the vagina to support pelvic organs. |
33 | $54 | $108 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
32 | $325 | $1,190 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
24 | $39 | $145 |
| Insertion of temporary bladder tube | 18 | $37 | $140 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $47 | $141 |
| Sacral nerve stimulator electrode insertion A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves. |
13 | $818 | $3,149 |
| Insertion of peripheral or gastric neurostimulator generator A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach. |
13 | $81 | $494 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
68.1% medium
31.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,955
Total received (2018-2024)
Avg $1,422/year across 7 years
Top 33% in NC for urogynecology and reconstructive pelvic surgery (urology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
369
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,128 (81.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,827 (18.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$711
2023
$1,796
2022
$3,460
2021
$2,054
2020
$434
2019
$780
2018
$722
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$248
Sumitomo Pharma America, Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$59
COLOPLAST CORP
$48
UROGEN PHARMA, INC.
$36
Teleflex LLC
$34
Astellas Pharma US Inc
$30
Medtronic, Inc.
$29
BLUEWIND MEDICAL
$28
Boston Scientific Corporation
$24
Blue Earth Diagnostics Limited
$24
LSI SOLUTIONS INC
$20
Cook Medical LLC
$19
Laborie Medical Technologies Corp.
$17
PROGENICS PHARMACEUTICALS, INC.
$15
Olympus America Inc.
$15
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$2,942
Astellas Pharma US Inc
$1,063
ABBVIE INC.
$559
Coloplast Corp
$530
Medtronic USA, Inc.
$496
Rochester Medical Corporation
$400
Axonics, Inc.
$340
Boston Scientific Corporation
$270
COLOPLAST CORP
$256
TOLMAR Pharmaceuticals, Inc.
$202
Sumitomo Pharma America, Inc.
$195
Blue Earth Diagnostics Limited
$179
Janssen Biotech, Inc.
$172
Merck Sharp & Dohme LLC
$144
PFIZER INC.
$143
UROVANT SCIENCES INC
$119
Antares Pharma, Inc.
$113
Bayer Healthcare Pharmaceuticals Inc.
$110
Dendreon Pharmaceuticals LLC
$100
Bayer HealthCare Pharmaceuticals Inc.
$86
ConvaTec Inc.
$85
Caldera Medical, Inc
$75
C. R. BARD, INC. & SUBSIDIARIES
$74
180 Medical, Inc.
$70
UroGen Pharma, Inc.
$65
Laborie Medical Technologies Corp.
$62
Progenics Pharmaceuticals, Inc.
$60
BOSTON SCIENTIFIC CORPORATION
$56
Myovant Sciences Inc.
$55
Allergan Inc.
$54
Allergan, Inc.
$49
Sun Pharmaceutical Industries Inc.
$45
Foundation Medicine, Inc.
$37
UROGEN PHARMA, INC.
$36
Ferring Pharmaceuticals Inc.
$35
Cook Medical LLC
$35
Endo Pharmaceuticals Inc.
$34
Amgen Inc.
$34
Teleflex LLC
$34
Olympus America Inc.
$33
Travere Therapeutics, Inc.
$31
BLUEWIND MEDICAL
$28
AbbVie Inc.
$27
EMD Serono, Inc.
$25
AMAG Pharmaceuticals, Inc.
$25
Bard Access Systems, Inc.
$24
Ethicon US, LLC
$23
Novartis Pharmaceuticals Corporation
$22
Ambu Inc.
$21
LSI SOLUTIONS INC
$20
C. R. Bard, Inc. & Subsidiaries
$19
PROCEPT BioRobotics Corporation
$19
DENTSPLY IH AB
$19
Agiliti Surgical, Inc.
$19
Merck Sharp & Dohme Corporation
$19
Avadel Specialty Pharmaceuticals, LLC
$18
Supernus Pharmaceuticals, Inc.
$16
Clarus Therapeutics Inc.
$16
NeoTract Inc.
$15
AbbVie, Inc.
$15
PROGENICS PHARMACEUTICALS, INC.
$15
TherapeuticsMD, Inc.
$14
DAVOL INC.
$14
BAXTER HEALTHCARE
$12
Clovis Oncology, Inc.
$11
Myriad Genetic Laboratories, Inc.
$11
RGH Enterprises, Inc.
$11
Top 3 companies account for 45.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADVANTAGE · ADVANTAGE FIT · AQUABEAM ROBOTIC SYSTEM · ARISTA AH · AVYCAZ · Altis · Axumin · BAVENCIO · BOTOX · BOTOX THERAPEUTIC · Bulkamid · COOK · COOK MEDICAL WIRE GUIDES · CYSTO-NEPHRO VIDEOSCOPE · Desara · ELIGARD · ERLEADA · FORNISEE · FOUNDATIONONE CDX · GEMTESA · GENERAL THERAPIES · GENERAL BPH · GENERAL THERAPIES · GENERAL BPH · GENTLECATH · GentleCath · IMVEXXY · INTERSTIM · INTRAROSA · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE EMPOWER · LUPRON DEPOT · LoFric · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · REVI · ReTrace · Restorelle · Rezum Generator · Rubraca · SURGICEL Family of Absorbable Hemostats · SpeediCath · TISSEEL · TLANDO · UROLIFT · Upsylon · UroLift · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urogynecology and reconstructive pelvic surgery physicians within 10 mi
1
Per 100K population
1.5
County median income
$70,235
Nearest hospital
CARTERET GENERAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Harris is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Harris experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Harris performed 5,550 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harris receive payments from pharmaceutical companies?
Yes. Dr. Harris received a total of $9,955 from 67 companies across 369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harris's costs compare to other urogynecology and reconstructive pelvic surgery physicians in Morehead City?
Dr. Harris's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harris) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urogynecology And Reconstructive Pelvic Surgery Physicians in Morehead City
Browse urogynecology and reconstructive pelvic surgery physicians in Morehead City ranked by procedure volume and transparency data.
Highest volume
Top Urogynecology And Reconstructive Pelvic Surgery Physicians in NC
Urogynecology and reconstructive pelvic surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urogynecology And Reconstructive Pelvic Surgery Physicians in NC
Which NC urogynecology and reconstructive pelvic surgery physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology